Back to Peptides
Peptides

HexarelinEvidence & Dosage

GH releaser, fast tolerance build-up, cardiac signals.

Evidence at a glance

Total studies
255
With abstract
49
Meta / Systematic / RCT
3
Highly cited
50
Publication years
1963–2026

Hexarelin in the context of Peptides

This topic is part of our "Peptides" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.

Go to Peptides

Top studies on Hexarelin

Ranked by influential-citation count and publication year.

  1. Hypoglycemia: a potent stimulus to secretion of growth hormone.

    Science (New York, N.Y.)1963200 influential citations

    In normal subjects, hypoglycemia produces an abrupt and sustained rise in levels of human growth hormone in plasma. This effect is independent of insulin, glucagon, or epinephrine. Prolonged fasting is accompanied by a rise in the hormone…

  2. Endocrine Activities of Ghrelin, a Natural Growth Hormone Secretagogue (GHS), in Humans: Comparison and Interactions with Hexarelin, a Nonnatural Peptidyl GHS, and GH-Releasing Hormone<sup>1</sup>

    The Journal of Clinical Endocrinology &amp; Metabolism2001120 influential citations

    An endogenous ligand for the GH secretagogue-receptor (GHS-receptor) has recently been isolated, from both the rat and the human stomach, and named ghrelin. It is a 28-amino-acid peptide showing a unique structure with an n-octanoyl ester…

  3. Regulation of muscle mass by growth hormone and IGF-I.

    British journal of pharmacology200891 influential citations

    Growth hormone (GH) is widely used as a performance-enhancing drug. One of its best-characterized effects is increasing levels of circulating insulin-like growth factor I (IGF-I), which is primarily of hepatic origin. It also induces…

  4. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man.

    Diabetologia198964 influential citations

    To elucidate the short-term actions of growth hormone on insulin sensitivity and forearm metabolism, we have studied six normal male subjects receiving a 6-h hyperinsulinaemic euglycemic clamp with and without a concomitant 4-h growth…

  5. Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man.

    The Journal of clinical endocrinology and metabolism199050 influential citations

    Primarily by increasing the availability of lipid intermediates, GH is likely to have profound effects on substrate consumption rates. To examine the short term actions of GH on glucose turnover, fuel oxidation and regional forearm…

  6. Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans.

    The American journal of physiology199140 influential citations

    To examine the insulin antagonistic effects of growth hormone (GH), seven healthy subjects underwent, in random order, two 5-h euglycemic clamp studies with moderate hyperinsulinemia. A GH infusion (45 ng.kg-1.min-1) was given throughout…

  7. Demonstration of a role for growth hormone in glucose counterregulation.

    The American journal of physiology198940 influential citations

    To test the hypothesis that growth hormone secretion plays a counterregulatory role in prolonged hypoglycemia in humans, four studies were performed in nine normal subjects. Insulin (15 mU.M-2.min-1) was infused subcutaneously (plasma…

  8. Once upon a time: the glucagon stimulation test in diagnosing adult GH deficiency.

    Journal of endocrinological investigation202440 influential citations

    <h4>Purpose</h4>The clinical features of adult GH deficiency (GHD) are nonspecific, and its diagnosis is established through GH stimulation testing, which is often complex, expensive, time-consuming and may be associated with adverse side…

  9. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults.

    The Journal of clinical endocrinology and metabolism1999n=1337 influential citations

    We prospectively studied two groups of GH-deficient patients during GH therapy based upon exposure of the liver to elevated (oral estrogen) or not elevated (endogenous or transdermal) sources of estrogen. We wondered whether higher…

  10. Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections?

    Current Neuropharmacology202537 influential citations

    Ghrelin is a gut peptide hormone associated with feeding behavior and energy homeostasis. Acylated ghrelin binds to the growth hormone secretagogue receptor 1a subtype (GHS-R1a) in the hippocampus, leading to GH release from the anterior…

More topics in Peptides

Peptides Overview

Peptides, BPC-157, TB-500, safety and the state of the evidence.

Administration Routes

Subcutaneous, intramuscular, nasal, oral, topical — bioavailability and safety.

Autoimmunity Risk

Immune modulation can both promote tolerance and tip into dysregulation.

BPC-157

Peptide for tissue regeneration, healing, and athletic recovery.

Cerebrolysin

A pig-brain peptide mix, stroke studies, not approved in Germany.

CJC-1295

GHRH analog, half‑life variants and pulse patterns.

Dihexa

Angiotensin derivative, cognitive/neuroplasticity signals in animal models.

GHK-Cu

Copper peptide for skin health, anti-aging, and wound healing.

GHRP-2

GH releaser, older generation, appetite stimulation as a side effect.

GHRP-6

GH releaser with a strong appetite component.

GLP-1 Rebound

Weight regain after stopping without lifestyle anchors.

GLP-1 Side Effects

Nausea, gastric emptying, muscle loss, pancreatitis risk.

IGF-1 LR3

Modified IGF-1 with a long half-life — hypertrophy, the cancer-risk debate.

Immune Modulation

Automatisch via Trend Scout entdeckt. Supplements targeting inflammation and immune resilience remain a central research area.. PubMed: 11956 Ergebnisse.

Injection Safety

Sterile technique, bacteriostatic water, skin disinfection — a medical topic.

Ipamorelin

Selective GH releaser, cortisol‑sparing, and stack combinations.

KPV

An alpha-MSH fragment — anti-inflammatory, gut, skin, early research.

Liraglutide

First-generation GLP-1 for diabetes/obesity — daily, smaller effect size.

LL-37

Antimicrobial peptide, wound healing, immune modulation, early research.

MK-677

Ghrelin mimetic, not strictly a peptide — sleep, appetite, glucose risk.

Related topics from other worlds